Chief Scientific Officer and Head of Research & Technology Development

WuXi Advanced Therapies

 

Dr. Shuyuan Yao received his PhD in molecular and medical genetics from The University of Toronto School of Medicine and accomplished postdoctoral research in stem biology at The Scripps Research Institute (TSRI), San Diego, California. From 2006 to 2014, Dr. Yao worked in Sangamo BioScience, StemGent Inc. and Allen Institute for Brain Science, and so on. In 2014, Dr. Yao moved back to China and worked at Vertex Pharmaceuticals R&D (Shanghai) Co., Ltd. Dr. Yao joined WuXi AppTec in November 2014. From 2014 to 2016, Dr. Yao served as Senior Director of Cell Therapy Research and headed the Cell Therapy Research Department. From 2016 to 2018, Dr. Yao served as VP of Operations at JW Therapeutics Co., Ltd., leading the company’s R&D, manufacturing, and operations. Dr. Yao now serves As Chief Scientific Officer and Head of Research & Technology Development of WuXi Advanced Therapies of WuXi ATU Co., Ltd. Dr. Yao has established and managed several start-up projects and companies and has strong experience in R&D, manufacturing, facility, team, and project management.